sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Microbiome Therapeutics Market...

2030年までのヨーロッパのマイクロバイオーム治療薬市場予測 - 地域分析 - タイプ別（治療薬と処置）、アプリケーション別（代謝性障害と肥満、C.ディフィシル感染症、炎症性腸疾患など）、エンドユーザー別（病院と診療所、外来手術センター） 、ホームケア、その他）

BMIRE00029955 | Pages: 71 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
ヨーロッパのマイクロバイオーム治療薬市場は、2022 年に 9,774 万米ドルと評価され、2030 年までに 2 億 1,252 万米ドルに達すると予想されています。 2022 年から 2030 年までに 10.2% の CAGR を記録すると推定されています。 マイクロバイオーム発見パイプラインを改善するための資金流入がヨーロッパのマイクロバイオーム治療薬市場を推進 調査では、マイクロバイオームの不均衡や混乱が、炎症性腸疾患や炎症性腸疾患などのさまざまな症状の一因となる可能性があることが示されています。肥満だけでなく精神的健康障害も。健康全般におけるマイクロバイオームの役割が認識されることにより、マイクロバイオームを標的にして調節する治療法の開発に大きな関心が集まっています。さらに、技術と研究ツールの進歩により、マイクロバイオームの研究と操作が容易になりました。次世代シークエンシングとメタゲノム解析により、微生物群集とその機能をより深く理解できるようになりました。知識の増加により、標的療法の開発に新たな可能性が開かれました。たとえば、2023 年 3 月、ドイツのマイクロバイオーム バイオテクノロジー企業 mbiomics GmbH は、効果的なマイクロバイオームに基づく第一世代の治療法を開発しました。 MIG Capital から 1,300 万ドル (1,500 万米ドル) の資金提供を受けました。この資金によりプラットフォームの構築が可能となり、ファーストリード医薬品候補の特定が加速され、臨床検証に向けた研究の取り組みが加速されることになる。強力な臨床証拠が利用可能になるにつれ、投資家はマイクロバイオーム調整企業に注目し始めています。資金調達の強化により、開発と生産の高コストに伴う課題を克服するために必要なリソースが企業に提供され、最終的にこの分野を前進させることができます。ヨーロッパのマイクロバイオーム治療薬市場の概要 ドイツのマイクロバイオーム治療研究会社は、マイクロバイオーム製品開発のために行われている研究の質を向上させるために、他の企業に研究活動への投資を呼びかけることに重点を置いています。 2023 年 3 月、マイクロバイオームに焦点を当てたドイツのバイオテクノロジー企業 mbiomics GmbH は、MIG Capital 主導のシリーズ A 資金調達ラウンドで約 1,500 万米ドル (1,300 万) を受け取りました。 mbiomics はその収益を戦略的パートナーシップに着手するために使用し、ミュンヘンの研究所施設とドイツの研究開発チームを大幅に拡大しました。一部の FMT 処置では、感染性病原体がドナーから患者に移る可能性があり、これが結果に影響を与えます。したがって、ドイツはマイクロバイオームまたは FMT 手順の使用について特別な規制を設けています。ドイツでは、FMT 薬は医薬品として規制されています。ただし、この製品の使用は、C. ディフィシル感染症や腸感染症などの症状に他の治療法が効果がない場合にのみ行うことができます。したがって、マイクロバイオーム治療薬の研究への投資が急増しているにもかかわらず、これらの治療製品の使用に関する規制は、ドイツにおけるヨーロッパのマイクロバイオーム治療薬市場の成長を妨げる可能性があります。ヨーロッパのマイクロバイオーム治療薬市場の収益と2030年までの予測（百万米ドル） ヨーロッパのマイクロバイオーム治療薬市場のセグメンテーション ヨーロッパのマイクロバイオーム治療薬市場は、タイプ、アプリケーション、エンドユーザー、および国に基づいて分割されています。ヨーロッパのマイクロバイオーム治療薬市場は、タイプに基づいて治療薬と処置に二分されます。 2022 年には処置部門がより大きなシェアを占めました。治療部門はさらに糞便微生物叢移植 (FMT)、プレバイオティクスおよびプロバイオティクスなどに細分化されています。ヨーロッパのマイクロバイオーム治療薬市場は、用途別に、代謝障害と肥満、クロストリジウム・ディフィシル感染症、炎症性腸疾患などに分割されています。 2022 年には代謝障害と肥満のセグメントが最大のシェアを占めました。ヨーロッパのマイクロバイオーム治療薬市場をエンドユーザー別にみると、病院や診療所、外来手術センター、ホームケアなどが占めています。病院および診療所セグメントは、2022年に最大のシェアを占めました。国に基づいて、ヨーロッパのマイクロバイオーム治療市場は英国、ドイツ、フランス、イタリア、スペイン、およびその他のヨーロッパに分割されています。 2022 年のヨーロッパのマイクロバイオーム治療薬市場はドイツが独占しました。Caelus Health BV、Enterome SA、Ferring Holdings SA、Vedanta Biosciences Inc、YSOPIA Bioscience SA は、ヨーロッパのマイクロバイオーム治療薬市場で事業を展開する大手企業です。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

5. Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - Europe Market Analysis

7. Europe Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Microbiome Therapeutics Market - Country Analysis

10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 UK

10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.3 Germany

10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.4 France

10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.5 Italy

10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.6 Spain

10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.7 Rest of Europe

10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Europe Microbiome Therapeutics Market

12. Company Profiles

12.1 YSOPIA Bioscience SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Enterome SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Caelus Health BV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vedanta Biosciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Microbiome Therapeutics Market Segmentation

Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type

Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics

Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application

Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User

Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market

Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market

List of Figures

Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. Caelus Health BV

2. Enterome SA

3. Ferring Holdings SA

4. Vedanta Biosciences Inc

5. YSOPIA Bioscience SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe microbiome therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports
    Report Name Published Date
    Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
    Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
    Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440
    GET FREE SAMPLE PDF
    Inquire before Buying Inquire for Discount
    Subscription Member Price: FREE
    Get Subscription